MedPath

Clinical Comparison of Two Silicone-Hydrogel Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error
Interventions
Device: galyfilcon A
Device: comfilcon A
Registration Number
NCT00762385
Lead Sponsor
Johnson & Johnson Vision Care, Inc.
Brief Summary

The objective of this study is to evaluate the clinical performance of two silicone-hydrogel contact lenses.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • The subject must be at least 18 and less than or equal to 39 years of age and have a need for vision correction in both eyes.
  • The subject must require a lens power between -1.00 to -6.00D and have no more than 1.00D of corneal cylinder.
  • The subject, based on his/her knowledge, must be in good general health.
  • The subject must be able and willing to adhere to the instructions set forth in this protocol and complete all specified evaluations.
  • Subject must be a current adapted daily wearer of soft contact lenses with at least 6 months of CL wear.
  • Subject must agree to wear their contact lenses in both eyes on a daily wear schedule for at least 8 hours per day every day during the study.
  • Subject must be willing and able to use only the care systems and lubricating drops provided for the study during the 4 week period.
  • The subject must read, indicate understanding of and sign the Informed Consent Form.
Exclusion Criteria
  • The subject is a rigid gas permeable (RGP) or daily disposable lens wearer.

  • The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids or associated structures.

  • The presence of ocular or systemic disease or need for medication which might interfere with contact lens wear or which would cause the lenses to be removed more than twice a day. (i.e., Sjogren's syndrome, type II diabetes, etc.)

  • Slit lamp findings that would contraindicate contact lens wear such as:

    • pathological dry eye or associated findings
    • pterygium or corneal scars within the visual axis
    • neovascularization equal to or greater than 1mm in from the limbus
    • history of giant papillary conjunctivitis (GPC) worse than grade 2
    • anterior uveitis or iritis (past or present)
    • seborrhoeic eczema
    • seborrhoeic conjunctivitis
  • A history of recurrent erosions, corneal infiltrates, corneal ulcer or fungal infections.

  • A known history of corneal hypoesthesia (reduced corneal sensitivity).

  • Contact lens snellen visual acuities (VA) worse than 20/30.

  • Aphakia, keratoconus or a highly irregular cornea.

  • Current pregnancy or lactation (to the best of the subject's knowledge)

  • Any active participation in another clinical study at any time during this study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
comfilcon A/galyfilcon Agalyfilcon Acomfilcon A first, galyfilcon A second
galyfilcon A/comfilcon Agalyfilcon Agalyfilcon A first, comfilcon A second
galyfilcon A/comfilcon Acomfilcon Agalyfilcon A first, comfilcon A second
comfilcon A/galyfilcon Acomfilcon Acomfilcon A first, galyfilcon A second
Primary Outcome Measures
NameTimeMethod
Lens Comfort1-week, 2- weeks

\>0 = comfortable, \<0 = uncomfortable; a weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes.

Comfort Symptoms1-week, 2-weeks

A weighted combined score calculated from individual comfort-related questions was used to derive comfort outcomes. \>0 = comfortable, \<0 = uncomfortable

Secondary Outcome Measures
NameTimeMethod
Overall Corneal Staining2 weeks

Measured for 5 zones of the cornea (superior, nasal, central, inferior, temporal)on a 0 to 3 grade scale (NEI 0-3 scale). Grade 0 = Normal/ grade 1 = mild, superficial stippling/ grade 2 = moderate, punctate staining including superficial abrasion of the cornea/ grade 3 = severe, abrasion or corneal erosion, deep corneal abrasion or recurrent erosion.

© Copyright 2025. All Rights Reserved by MedPath